1. Home
  2. TACH vs ABSI Comparison

TACH vs ABSI Comparison

Compare TACH & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TACH
  • ABSI
  • Stock Information
  • Founded
  • TACH 2024
  • ABSI 2011
  • Country
  • TACH United States
  • ABSI United States
  • Employees
  • TACH N/A
  • ABSI N/A
  • Industry
  • TACH
  • ABSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • TACH
  • ABSI Health Care
  • Exchange
  • TACH Nasdaq
  • ABSI Nasdaq
  • Market Cap
  • TACH 350.2M
  • ABSI 338.0M
  • IPO Year
  • TACH 2025
  • ABSI 2021
  • Fundamental
  • Price
  • TACH $10.13
  • ABSI $2.39
  • Analyst Decision
  • TACH
  • ABSI Strong Buy
  • Analyst Count
  • TACH 0
  • ABSI 5
  • Target Price
  • TACH N/A
  • ABSI $7.98
  • AVG Volume (30 Days)
  • TACH 357.0
  • ABSI 4.4M
  • Earning Date
  • TACH 01-01-0001
  • ABSI 08-12-2025
  • Dividend Yield
  • TACH N/A
  • ABSI N/A
  • EPS Growth
  • TACH N/A
  • ABSI N/A
  • EPS
  • TACH 0.19
  • ABSI N/A
  • Revenue
  • TACH N/A
  • ABSI $4,138,000.00
  • Revenue This Year
  • TACH N/A
  • ABSI $44.71
  • Revenue Next Year
  • TACH N/A
  • ABSI $374.26
  • P/E Ratio
  • TACH $144.19
  • ABSI N/A
  • Revenue Growth
  • TACH N/A
  • ABSI 27.32
  • 52 Week Low
  • TACH $9.51
  • ABSI $2.01
  • 52 Week High
  • TACH $11.00
  • ABSI $6.33
  • Technical
  • Relative Strength Index (RSI)
  • TACH N/A
  • ABSI 33.33
  • Support Level
  • TACH N/A
  • ABSI $2.50
  • Resistance Level
  • TACH N/A
  • ABSI $2.73
  • Average True Range (ATR)
  • TACH 0.00
  • ABSI 0.18
  • MACD
  • TACH 0.00
  • ABSI -0.04
  • Stochastic Oscillator
  • TACH 0.00
  • ABSI 1.94

About TACH Titan Acquisition Corp. Class A Ordinary Shares

Titan Acquisition Corp is a blank check company.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Share on Social Networks: